Add Yahoo as a preferred source to see more of our stories on Google. A Cell Metabolism study reports that EVT0185 reduced scarring in disease models and may offer a new path for treating MASH.

Fifty percent of T2DM patients also have NAFLD, confirmed via ultrasound, with elevated liver enzymes and altered lipid profiles. NAFLD and T2DM are key components of metabolic syndrome, sharing risk ...

A new study published in Science Advances reveals that a single gene plays a big role in how the liver stores energy, a process that's critical for overall health and for managing diseases like type 2 ...

For long-term type 2 diabetes management, focus is shifting from blood sugar numbers to the scale. Learn why losing 15% of body weight may be the key to resetting your pancreas and achieving remission ...

SGLT-2 inhibitors, compared with DPP-4 inhibitors, were associated with a lower risk for liver cirrhosis among patients with type 2 diabetes. Sodium-glucose cotransporter 2 (SGLT-2) inhibitors, ...

Excess sugar challenges body systems, raises blood sugar, and links to weight gain, fatty liver, diabetes, and heart disease.

Forbes contributors publish independent expert analyses and insights. Jesse Pines is an expert in healthcare innovation and wellness. Continuous glucose monitors are small, wearable devices that track ...

A diagnosis of serious liver disease can feel like a slow countdown. Scar tissue builds quietly, the liver stiffens, and the risks climb toward cancer, heart attack, stroke, and even transplant. Now, ...